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Clearance  of microparticulate  fibrin  by the  reticuloendothelial  system has 
been  long  recognized  as  a  defense  mechanism  against  intravascular  fibrin 
deposition  (1, 2). In general this has been assumed to be part of the relatively 
nonspecific phagocytic process whereby the reticuloendothelial system removes 
other microparticulate material such as bacteria, from the circulation.  Numer- 
ous in  vitro  studies  (3-7) have  documented the  fact that  before formation  of 
particulate fibrin, fibrin may exist in a soluble form, generally when in a soluble 
complex with fibrinogen, and/or fibrin degradation products (5-7).  Recently we 
have demonstrated that soluble macromolecular complexes consisting of known 
ratios of fibrinogen and fibrin which were formed in vitro, remain soluble when 
injected into  rabbits  (7). These  complexes  also  had  impaired  clearance  from 
blood during reticuloendothelial system blockade with Thorotrast. In nonblock- 
aded animals,  the blood tl/2 of the fibrinogen/fibrin complex was less than  1 h. 
The results  indicated that  in part reticuloendothelial  system uptake  of fibrin 
depended on specific binding  of soluble fibrin,  before microparticle  formation 
and  phagocytosis.  Specificity for  fibrin  was  suggested,  because  in  the  same 
Thorotrast model we were unable to demonstrate impaired clearance of fibrino- 
gen degradation  product D  (8),  and intact fibrinogen had a  normal  blood tV2. 
Removal of soluble fibrinogen/fibrin  complexes is of pathophysiological signifi- 
cance because of the clear, frequent clinical association of these complexes with 
intravascular  coagulation  (9-12), in contrast to the very rare demonstration of 
circulating microparticulate fibrin. 
To explore further  the soluble fibrin-reticuloendothelial  system interaction, 
and a possible surface receptor, in the present report, isolated peritoneal macro- 
phages have been studied for their ability to bind soluble fibrin, fibrinogen, and 
other fibrinogen derivatives. 
Materials  and Methods 
Fibrinogen  and Derivatives.  Human fibrinogen fraction I-4  was purified by the method of 
Blomback and Blomback (13) to ->95% clottability. Fibrinogen was labeled with ~31I or ~25I by the 
method of McFarlane (14) with -<0.5 atoms iodine/mole fibrinogen and >-94% radioactive clottabilo 
ity. The radiolabeled fibrinogen (F) 1  was converted to fibrin (f) by thrombin and the resultant clot 
* Supported by NIH Specialized Center of Research in Thrombosis grant no. HL-14147. 
1  Abbreviations  used in this paper:  CIG, cold-insoluble globulin; CTA, Committee on Thrombo- 
lytic Agents; f, soluble fibrin; F, fibrinogen; HBSS, Hanks' balanced salt solution; PMNs, polymor- 
phonuclear leukocytes; SBTI, soy bean trypsin inhibitor. 
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Fro.  1.  Sepharose 4B chromatography of 'zsI-f/13ff-F complex. (---),  '3'I-F; (-),  'SSl-f; Vo, 
void volume; F,  elution point of ~3~I-F alone.  Column buffer is  0.3  M  Tris-C1,  0.001  M 
disodium EDTA, and 0.015  M tosyl arginine methyl ester. 
was redissolved in 0.27 M Tris HC1, 0.03 M Tris-acetate buffer, pH 5.3, as previously described (7). 
In some instances, the soluble fibrin was added to fibrinogen to form fibrin/fibrinogen complexes 
(f/F).  These complexes are large polymers which emerge at the void volume on Sepharose 4B and 
have a  Ve/Vo of 1.17 on Sepharose 2B.  A double labeled ~25I-f/13'I-F preparation illustrates that 
both F  and f  are  present in the void volume complex  (Fig.  1).  A  second peak contains some 
noncomplexed F  and a  small variable amount of f. The second peak corresponds to the Ve of F 
alone. '25I-f alone emerges at the void volume with a small amount in the F position (7). Thrombin 
neutralization was accomplished with 10 -2 M diisopropylfluorophosphate.  In some instances f was 
formed in the presence of Ca ++ so as to obtain cross-linked f. "Late" crude plasmin digests of F  (F 
degradation products) were prepared by addition of 30 U streptokinase to 24 mg F in 0.1 M Tris-C1 
buffer, pH 8.4,  and incubation at 37°C for 18 h. Late fibrin degradation products were similarly 
prepared except that thrombin was added just before the streptekinase. For "early" fibrin degrada- 
tion products, soy bean trypsin inhibitor (SBTI) was added at the time of clot dissolution. 
Macrophages.  Guinea pig peritoneal macrophages were harvested 3 days after intraperitoneal 
injection of 20 ml Marcol 52 (Humble Oil & Refining Co., Houston, Texas) (15). The cell suspension 
was washed and resuspended in RPMI 1640, with 10% fetal calf  serum. The cells were incubated in 
glass Petri dishes for 18 h at 37°C in 5% CO2. The contaminating lymphocytes were poured off, and 
the adherent macrophages washed with Hanks' balanced salt solution (HBSS). The macrophages 
were  harvested  with  a  rubber  policeman,  washed,  and  resuspended in  HBSS.  Resuspended 
macrophages were ->90% viable by trypan blue exclusion and ->90% of  the cells phagocytized yeast 
particles. 
Other Cell Types.  Washed guinea pig lymphocyte suspensions were prepared from the nonad- 
herent cells after overnight culture of the Marcol-induced peritoneal exudates. Cultures of human 
skin fibroblasts were kindly supplied by Dr. Nancy Baenziger. Guinea pig peritoneal polymorpho- 
nuclear leukocytes (PMNs) were harvested 18 h after injection of 20 ml of 6% caseinate (15). The 
exudates contained ->96% PMNs. 
Experimental.  For  most experiments 1.5  x  106  cells were suspended in  HBSS  or  0.007  M 
NaH2PO4,  0.15  M  NaC1,  pH  7.4  buffer, in Falcon  12  ×  75  mm tubes  (Falcon Plastics, Div.  of 
BioQuest, Oxnard, Calif.) Cellular metabolism was inhibited with either 1 x  10  2 M NaF and 2 × 
10 -2 M KCN or 20 mM 2-deoxyglucose and 1 mg/ml sodium azide. Varying amounts of '25I-for ~25I-f/ 
F were then added and the total radioactivity measured. Unless so indicated, incubations were for 
45 min. 22°C was usually employed because it was desirable to avoid enhanced metabolic activity 
at 37°C, yet f is poorly soluble at 4°C.  The experiments comparing maerophages, lymphecytes, 
fibroblasts, and erythrocytes were at 37°C because it is known that f/F will bind soluble fibroblast 
surface antigen, or cold-insoluble globulin  (CIG),  at  low temperatures, but not at 37°C.  After 
incubation, the ceils were centrifuged for 5 min at 2,500 g  and 22°C, and the supernate removed. 
Two washes of the cells with HBSS were performed. Preliminary studies demonstrated that no 
additional radioactivity was removed by added washes. The cell-bound radioactivity was deter- 
mined in a Packard dual channel gamma counter (Packard Instrument Co., Inc., Downers Grove, 
Ill.). In instances when both ~zq and '25I were used, the 'z~I counts were corrected for the scatter of 
~a~I counts into the '~I channel. Blank controls with ~I-f or '25I-f/F but without cells were also run. 78  SPECIFIC  BINDING  OF  SOLUBLE  FIBRIN  TO  MACROPHAGES 
Centrifugation of-<20 ttg '25I-f or -<500 /zg ~2~I-f/F in HBSS at 7-10,000 g  for 20 min without cells, 
showed neither a precipitate nor significant change in the specific activity of the solution. This is 
in keeping with previous data (7) that the f/F complex remains both soluble, and as a complex, in 
the blood of animals after injection of f/F. All tests were run in duplicate or triplicate. The amount 
bound was usually expressed as micrograms per l0  s cells, and was corrected for the blank controls, 
which did not exceed 5% of the cell-bound values. 
Specificity.  The specificity of binding was assessed first by the effect of prior incubation of the 
cells with nonradioactive f and F. Secondly the interaction with the IgG receptor was assessed for 
both IgG and immune complexes. For immune complexes, rat IgE and goat anti-IgE were kindly 
supplied by Dr. A. Kulczycki (16). A 25-fold range of IgE was used so as to span the previously 
determined range of equivalence. The antisera concentration was 0.15 ml in 0.5 ml final test vol. 
The  same  amount  of human  IgG  was  used  for IgG  alone.  Human  IgG  was  prepared by  ion 
exchange chromatography and was immunoelectrophoretically homogeneous using anti-human 
IgG and anti-whole human sera (Behring Diagnostics, American Hoechst Corp., Somerville, N. 
J.). Because of the high protein concentration, a  control with a similar amount of human serum 
albumin (Hyland Laboratories, Los Angeles, Calif.) was run. 
Effects of Trypsin and Plasmin 
PRETREATMENT.  Cells were preincubated with either 0.25  mg/ml trypsin  (Sigma Chemical 
Co., St. Louis, Mo.) and 0.4  mg/ml ribonuclease (Worthington Biochemical Corp., Freehold, N. 
J.), or 3 Committee on Thrombolytic Agents (CTA) U plasmin (17) for 30 min at 37°C. 0.5 mg/ml 
SBTI was added, the supernate removed, and the cells washed twice and resuspended for addition 
of labeled f or f/F. 
POSTFIBRIN  EXPOSURE.  In other experiments, after incubation with radiolabeled f or f/F, the 
ceils were centrifuged, washed, and the bound radioactivity counted. HBSS was readded with 1 
mg/ml of  trypsin or 3 CTA  ~  U plasmin for 20 min at 37°C. The cells were recentrifuged, washed, and 
radioactivity recounted. 
Effect of  Divalent Cations.  The macrophages were suspended in HBSS solution with metabolic 
inhibitors, without Ca ++ or Mg  ++, and 125I-f  added. Other tubes had 0.9 mM CaC12 or 0.5 mM MgC1, 
and 0.4 mM MgSO4 added before addition of the ~25I-f. The entire experiment was run with both 
cross-linked and noncross-linked l~sI-f. Experiments with noncross-linked  f and Ca ++ utilized 10 -3 
M iodacetamide to inhibit any trace F  XIII activity. 
Results 
Binding of Derivatives  (Table I).  In the standard incubations both fand f/F 
complexes were bound to the macrophages. Intact F, late F degradation products, 
and late f  degradation products were bound in much smaller amounts.  When 
early 125I-f  degradation products were mixed with F before addition to the tubes, 
1.5  /zg  early  12~I-f degradation  products  was  bound  per  l0  s  cells.  No  such 
enhanced binding was observed when F and early F degradation products were 
mixed together before addition to the cells. Binding was progressive until 30 rain 
and remained essentially constant thereafter  (Table II). 
Localization  of 125I-f.  To differentiate between membrane-bound and intra- 
cellular  125I-f, after  incubation  with  ~25I-f, cells  were  washed,  counted,  and 
reincubated with plasmin or trypsin (Table III a). Essentially, all the cell-bound 
radioactivity was removed, by either enzyme. 
Binding  Sensitivity  to  Pretreatment  with  Plasmin  and  Trypsin  (Table 
III b).  Cells pretreated with plasmin and trypsin retained  ~25I-f  binding capa- 
bility.  125I-f/F demonstrated the same binding characteristics as ~2~I-f alone. 
Concentration  Dependence of f  and f/F Binding.  To examine the effect of 
higher concentrations of f, f/F was used because of the marginal solubility of f 
alone in concentrations above 20/~g/ml. Increasing concentrations off/F reached 
a plateau  at approximately 5.4  /~g or 3.6  /~g f/10  + macrophages  (Fig.  2).  Scat- LAURENCE  A.  SHERMAN  AND  JOAN  LEE 
TABLE  I 
Macrophage  Binding ofF Derivatives 
Derivative  ~g protein bound/108 cells* 
I~I-F  0.05 _ 0.025 
Soluble 125I-f  1.7  _+ 0.3 
z~I-f/F complex  1.4  _+ 0.2 
Late 125I-FDP$  0.09 _+ 0.01 
Late xzsI-fdp$  0.10 ± 0.03 
Early ~2~I-fdp and F  1.5  ± 0.2 
Late ~I-fdp and F  0.15§ 
Early 125I-FDP  and F  0.06§ 
Late ~25I-FDP  and F  0.07§ 
* Mean _+ SD of four experiments. 
$ FDP, F degradation products;  fdp, f degradation products. 
§ Two experiments. 
TABLE II 
Micrograms  of f Bound vs. Time 
Time  ~g f bound/106 cells 
rain 
5  0.24 
10  0.56 
20  1.28 
30  1.52 
45  1.70 
90  1.65 
120  1.67 
180  1.70 
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TABLE HI 
Effect of Plasmin and Trypsin 
a. Plasmin or trypsin added after 125I-f 
binding  #g ~25I-f  bound* 
Pre-enzyme  1.3  _+ 0.2 
Post-trypsin  0.12 ± 0.07 
Post-plasmin  0.17 ± 0.06 
b. Plasmin or trypsin treatment of cells before  125I 
Untreated cells  1.6 _+ 0.3 
Trypsin treated cells  1.4 _+ 0.2 
Plasmin treated cells  1.5 _+ 0.2 
* Mean and _+ 1 SD for three experiments. 
chard  analysis of the  data  from  experiments with  two  different macrophage 
preparations, indicated an average of 1.15  ×  10 -17 mol or 6.92  ×  106 molecules 
bound  per  macrophage  (Fig.  3).  Because  both  soluble  f  and  f/F  consist  of 
molecular  aggregates  or  polymers,  the  number  of binding  sites  per  cell  is 
probably less. Calculation of the number of sites would require accurate molecu- 
lar size data for the complexes. The large size of the complexes, and the known 
anomalous behavior of F  on gel  chromatography  makes  such  size  estimates 
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FIG. 3.  Scatchard analysis of moles 12sI-f  bound with increasing concentrations. ;2sI-f  was 
in  a  ;25I-f/F complex. Symbols (©,  A) represent  two separate  sets  of experiments,  r/c, 
bound per unbound x 102. 
Reversibility and Displacement.  With an incubation of 1 tzg f with 1.5  ×  10  s 
cells for 45 min,  14%  (0.14  tzg)  was bound.  Subsequent dilution to  10 ml with 
addition of 50 tLg nonradiolabeled f and reincubation for 45 min failed to displace 
any 12sI-f. Similar experiments with ratios of 10-800:1 of "cold": 125I-f  and incuba- 
tion  for  up  to  180  min,  all  failed  to  demonstrate  significant  displacement. 
Prolonged incubation  of cells  with  ~25I-f alone did  not show either  significant 
further  uptake  after  45  min,  or  release  of radioactivity.  Displacement  only 
occurred  in  three  experiments  with  cold  f:  ~2~I-f ratios  of 500:1  and  a  20  h 
incubation period.  31  _+  10%  of the  cell-bound radioactivity was  released.  In 
contrast  cells  incubated  without  metabolic  inhibitors  showed  sustained  in- 
creases in radioactivity (Fig.  4).  After overnight incubation without inhibitors, LAURENCE  A.  SHERMAN  AND  JOAN  LEE  81 
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TABLE IV 
Interaction of IgG, Soluble f, and Macrophages 
Amount of  % Inhibition of 
rat IgE  ~25I-f binding 
1. Albumin (6 rag/tube) 
2. Human IgG (1 mg/tube) 
3. Goat anti-rat IgE (150 ~l) 
4. Immune complex 
5. Immune complex 
6. Immune complex 
-  21 
-  17 
-  19 
0.0055  24 
0.0275  14 
0.1375  19 
Incubation mixture included 1.5 ×  10  e cells and 10 ~g l~sI-f. Tubes 3-6 had 0.15 
ml of undiluted goat antisera added per tube. The amount bound with 12sI-fand 
cells alone was considered 100%. The results are the average of three experi- 
ments with albumin and two experiments with the others. 
11% of the unbound 125I was TCA soluble, indicating cellular proteolysis of 125I-f 
with release of free 12sI. 
Specificity.  Prior incubation of cells with 100 P4g nonradioactive f/F reduced 
uptake of 10 ~g 125I-fby 71 _+ 4% in three experiments. Preincubation with a  10- 
fold excess of F  failed to inhibit uptake of ~25I-f. Immune complexes and IgG 
alone inhibited uptake by 14-24% (Table IV). A similar decrease was seen with 
albumin.  The modest nature of the decreased uptake in light of the 200- and 
3,000-fold molar excesses of IgG and albumin suggests the effect was nonspecific. 
The f  uptake  with  albumin  (1.48  p~g/106 cells) may represent a  physiological 
state, more comparable to in vivo conditions, than with HBSS alone. 
Effect of Divalent Cations  (Table V).  When the  125I-f  uptake was tested in 
Hanks' solution without Ca ++ or Mg +÷, negligible uptake occurred. Addition of 
Ca ÷+ alone restored f binding, whereas Mg ÷+ alone had no effect. The effect of 
Ca +÷ was present with both cross-linked fibrin and noncross-linked f. 
Other Cell Types.  A limited number of studies were performed with PMNs. 
The same  enhanced binding  of f  vs.  F  was  found as  with  the  macrophages. 
Substantially greater  amounts  of f  were  bound  to  PMNs  as  compared with 
macrophages. In the presence of 10 ~g f and NaF and KCN, 4.9  _+ 0.4  ~g 125I-f 
bound/106 cells in five experiments. Lymphocytes, fibroblasts, and erythrocytes 
bound relatively little ~25I-ffF, as compared with macrophages and PMNs.  The 
lymphocytes and fibroblasts bound approximately as much F as f (Table VI). 82  SPECIFIC  BINDING  OF  SOLUBLE  FIBRIN  TO  MACROPHAGES 
TABLE V 
Effect of Cross-Linking and Divalent Cations on Binding 
Cross-linked f with Ca ++ 
Cross-linked f without Ca ++ 
Noncross-linked f with Ca ++ 
Noncross-linked f without Ca ++ 







TABLE  VI 
Comparative Binding off to Various Cells 
Cells 
~g bound/106 cells 
~2~I.  f  ~25I.  F 
Macrophages  1.8  0.05 
Lymphocytes  0.17  0.08 
Fibroblasts  0.19  0.18 
Erythrocytes  0.09  0.03 
Macrophage, lymphocyte, and erythrocyte values are the means of three 
experiments. Fibroblast results are means of two experiments. 
Discussion 
The  cellular  uptake  of soluble f  and  f/F  complexes  described above would 
appear  to  be  the  result  of cell  surface  binding.  Intracellular  ingestion  was 
prevented by use of metabolic inhibitors. Subsequent removal of the cell-bound f 
by trypsin and plasmin was added evidence that the f was on the outside of the 
cells. A major concern was the possibility that the f and f/F were artifactually 
precipitated or polymerized with the cells. The low binding in the blank controls 
and  other  cell  types  except  PMNs  (Table  VI),  and  the  unchanged  specific 
radioactivity  of 12~I-f and  l~I-f/F  in  HBSS after  centrifugation,  are  evidence 
against precipitation.  Additionally,  saturation  of uptake above 300  ~g (Fig.  2) 
and the blocking of uptake by cold f/F makes precipitation unlikely. If precipita- 
tion,  or  further  polymerization  were  occurring,  increasing  amounts  of  cell 
radioactivity  would result  from  increasing  the  f/F  concentration.  In  fact  an 
increasing  percentage  of cell-bound  f  would  be  expected,  and  the  opposite 
occurred. 
The high uptake of 125I-f  by PMNs is not clearly explicable. Cellular metabo- 
lism may have been incompletely inhibited, however, as with the macrophages, 
virtually  all the  cell-bound  125I-f could be removed by subsequent plasmin  or 
trypsin treatment.  PMNs have been previously shown to have a great capacity 
to phagocytize and lyse particulate f. Lewis et al.  (18) demonstrated 200-320  × 
l0 s  cells  could  lyse  6  mg  particulate  f  in  3  h.  This  area  requires  further 
investigation. 
The nature of the binding site on the macrophage is unknown. The possibili- 
ties existed of previously absorbed or synthesized F, f, or CIG binding the ~2sI-f 
and ~25I-f/F. CIG is a recently described plasma protein  (19) which can be cross- 
linked to f (20) and is thought to be identical to fibroblast surface antigen  (21). LAURENCE  A.  SHERMAN  AND  JOAN  LEE  83 
The likelihood of cellular F  or f binding the 125I-f  was essentially eliminated by 
continued  binding  after  pretreatment  with  trypsin  or  plasmin.  CIG  is  also 
susceptible to trypsin and plasmin (M. W. Mosesson, personal communication). 
Additionally,  in  the  experiment  comparing  macrophages,  lymphocytes,  and 
fibroblasts (Table VI), the macrophages bound fat 37°C.  CIG has been reported 
not  to bind  f  at  37°C  (21). Although  not  excluded,  it  is  unlikely  that  other 
adherent  proteins,  or residual  F  or  CIG fragments,  might  bind f, but rather 
some type of membrane receptor is involved. The rapid uptake of f and f/F is 
similar to that  noted for IgG and  complement.  The  quantitative  relation be- 
tween number of f molecules bound and the number of binding sites per cell is 
uncertain  because the protein  is not monomeric.  In the  conditions  employed, 
both f and f/F exist as macromolecular complexes, of an unknown mean number 
of molecules. Therefore the number of binding sites per cell is less than 6.92  × 
106, as each site binds a polymer containing several f molecules. The number of 
molecules bound is comparable to the results reported for IgG-binding sites of 
0.4-2.5  ×  106 per cell (22-25). 
Relatively little F, late F  degradation products, and late f degradation prod- 
ucts were bound as compared to f, implying a specificity of uptake that is unique 
to relatively intact f. The observed uptake of ~alI-F in f/F complexes was expected 
based on our previous data (7) indicating the complex is stable in a soluble state. 
Early f degradation products have also been noted to form large complexes (6). 
Colvin and  Dvorak  (26) described macrophage  uptake  of homologous F  using 
immunofluorescence to detect the protein. It was also surmised that some of the 
material  was  f  because of a  net-like  pattern  which  was  absent in  warfarin- 
treated  animals.  Direct  evidence for f  binding  was  not  obtained.  As  in  the 
present  results,  Ca ++  was  necessary  for binding.  Our  results  suggest  that  f 
binding may be by a  different mechanism than F in that preincubation with F 
did not block 12~I-f  uptake, whereas preincubation with f did. The binding of F in 
the study of Colvin and Dvorak and in the present results may be secondary to 
several phenomena.  It is very difficult to avoid slight denaturation  of F during 
purification  and radiolabeling  (27).  This denatured fraction is rapidly cleared 
from the blood after injection  (28), presumably in the liver and spleen.  Part of 
the small amount of F  bound could represent denatured  material.  Conversely 
Colvin and Dvorak's positive results with direct staining of cells without prior 
incubation in plasma would suggest that nonartifactual  binding does occur, at 
least  in  part.  They  have  hypothesized  that  F  is  important  in  macrophage 
adherence.  The quantitatively greater amounts of f binding found here and the 
evidence for ingestion noted here (Fig. 4), and by Chang and Boxer (29), indicate 
a  different role for f binding. 
Soluble f binding would appear to be the initial step in blood f clearance before 
ingestion and intracellular  catabolism. The very limited reversibility of f bind- 
ing  would  be  in  keeping  with  this  function.  It  would  appear  that  via  this 
mechanism,  the reticuloendothelial  system is capable of preventing thrombus 
formation before formation of microparticulate f. The quantitative differences in 
binding of F, f, F  degradation products, and f degradation products, suggest a 
fine  biochemical  discrimination  on  the  cell  surface,  in  keeping  with  such  a 
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Summary 
Guinea  pig  peritoneal  macrophages  were  demonstrated  to  bind  selectively 
soluble 125I-fibrin and fibrin/fibrinogen complexes as compared with fibrinogen, 
fibrinogen degradation products,  and fibrin degradation products.  Cellular up- 
take was considered to be surface receptor binding on the basis of removal of 
bound  125I-fibrin  by  trypsin  and  because  uptake  occurred  in  the  presence  of 
metabolic inhibitors.  125I-fibrin uptake could be blocked by nonradioactive fibrin 
but not by IgG or immune complexes. Binding was uneffected by prior treatment 
with plasmin or trypsin but was calcium dependent.  Only limited reversibility 
of binding  could be demonstrated  after prolonged incubation.  Scatchard  plots 
permitted an estimate of the number of bound molecules.  At saturation 6.92  × 
106 125I-fibrin molecules were bound per cell. Similar binding of fibrin was noted 
in  polymorphonuclear leukocytes,  but  not  lymphocytes or fibroblasts.  Soluble 
fibrin binding may be a  host defense mechanism whereby the reticuloendothe- 
lial system can remove fibrin from the blood before the development of micro- 
thrombi. 
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